Patent Assignment
Reel/Frame 031519/0773
Assignment of Assignor's Interest
Recorded: 2013-10-31
Pages: 3
Assignor
NATIONAL RESEARCH COUNCIL OF CANADA
Executed: 2013-09-26
Assignee
ALETHIA BIOTHERAPEUTICS INC.
141 PRESIDENT-KENNEDY AVE, SB-5100, MONTREAL, H2X1Y4, CANADA
Covered Property
(1)
Antibodies That Specifically Block the Biological Activity of Kidney Associated Antigen 1 (KAAG1)
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 19, 2013
From: SULEA, TRAIAN
To: NATIONAL RESEARCH COUNCIL OF CANADA
Reel/Frame 030041/0918 →
Assignment of Assignor's Interest
Mar 19, 2013
From: TREMBLAY, GILLES BERNARD; FILION, MARIO
To: ALETHIA BIOTHERAPEUTICS INC.
Reel/Frame 030041/0863 →
Assignment of Assignor's Interest
Jun 30, 2017
From: ALETHIA BIOTHERAPEUTICS INC.
To: ADC THERAPEUTICS SA
Reel/Frame 042880/0186 →
Security Interest
May 19, 2020
From: ADC THERAPEUTICS SA
To: DEERFIELD PARTNERS, L.P., AS GRANTEE
Reel/Frame 052696/0247 →
Ip Pledge Agreement
Jun 29, 2020
From: ADC THERAPEUTICS SA
To: DEERFIELD PARTNERS, L.P.
Reel/Frame 053080/0309 →
Termination and Release of Patent Security Agreement
Aug 16, 2022
From: DEERFIELD PARTNERS, L.P.
To: ADC THERAPEUTICS SA
Reel/Frame 061200/0750 →
Patent Security Agreement
Dec 27, 2022
From: ADC THERAPEUTICS SA
To: OWL ROCK OPPORTUNISTIC MASTER FUND I, L.P.
Reel/Frame 062228/0763 →